[{"type": "title", "data": "ICU COVID-19 Tocilizumab (Module)"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "Ordering of tocilizumab or baricitinib is restricted to Critical Care physicians OR COVID-19 Unit Internists OR Infectious Diseases physicians per site restrictions", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Patients admitted to hospital for more than 14 days with symptoms of COVID-19 should NOT receive tocilizumab or baricitinib for COVID-19", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Inclusion criteria\ntocilizumab or baricitinib should be administered within 24 hours of initiation of life support due to confirmed COVID-19, including:\n- high-flow oxygen support (e.g., Optiflow) with flow rate greater than 30 L/min and FiO2 greater than 0.4\nOR\n- invasive or non-invasive mechanical ventilation \nOR\n- vasopressor or inotropic support", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "note", "data": "Exclusion Criteria - Do NOT use tocilizumab if:\n- ANC is less than 1 x 10^9/L\n- Platelets are less than 50 x 10^9/L\n- ALT or AST is greater than 5 times the upper normal limit\n- Active serious infection other than COVID-19\n- Known condition or treatment resulting in ongoing immune suppression including neutropenia prior to hospitalization\n- Receipt of one or more doses of interferon, anakinra, tocilizumab, or sarilumab during this hospitalization or on longterm therapy", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "sentence", "data": "None"}, {"type": "category", "data": "Medication"}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "acetaminophen", "value": ""}, {"type": "sentence", "data": "650 mg, PO, as directed, order duration: 1 doses or times, drug form: tab"}, {"type": "order", "data": "diphenhydrAMINE", "value": ""}, {"type": "sentence", "data": "50 mg, PO, as directed, order duration: 1 doses or times, drug form: cap"}, {"type": "order", "data": "dimenhyDRINATE", "value": ""}, {"type": "sentence", "data": "50 mg, IV, as directed, order duration: 1 doses or times, drug form: inj"}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "tocilizumab", "value": "checked"}, {"type": "sentence", "data": "400 mg, IV once, drug form: inj"}, {"type": "note", "data": "If tocilizumab is not available, order baricitinib. Baricitinib should be continued for 14 days or until hospital discharge, whichever is sooner", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "baricitinib ", "value": ""}, {"type": "sentence", "data": "4 mg, PO, qdaily, order duration: 14 day"}, {"type": "sentence", "data": "4 mg, NG-tube, qdail, order duration: 14 day"}, {"type": "note", "data": "For patients with GFR 30 to 59 mL/min", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "baricitinib", "value": ""}, {"type": "sentence", "data": "2 mg, PO, qdaily, order duration: 14 day"}, {"type": "sentence", "data": "2 mg, NG-tube, qdaily, order duration: 14 dya"}, {"type": "note", "data": "For patients with GFR 15 to 29 mL/min", "value": ""}, {"type": "sentence", "data": "None"}, {"type": "order", "data": "baricitinib", "value": ""}, {"type": "sentence", "data": "2 mg, PO, q2day, order duration: 14 day"}, {"type": "sentence", "data": "2 mg, NG-tube, q2day, order duration: 14 day"}]
